Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113742663 | 11374266 | 3 | F | 2015 | 20160623 | 20150812 | 20160704 | EXP | ES-AMGEN-ESPSP2015081787 | AMGEN | 50.00 | YR | A | F | Y | 0.00000 | 20160704 | CN | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113742663 | 11374266 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | N | L18677 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 113742663 | 11374266 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | N | L95482 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 113742663 | 11374266 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, UNK | N | M90735 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||
| 113742663 | 11374266 | 4 | C | VIMOVO | ESOMEPRAZOLE MAGNESIUMNAPROXEN | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 113742663 | 11374266 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
| 113742663 | 11374266 | 6 | C | PALEXIA | TAPENTADOL HYDROCHLORIDE | 1 | 2 DF, 2X/DAY | 0 | 2 | DF | BID | ||||||||
| 113742663 | 11374266 | 7 | C | PALEXIA | TAPENTADOL HYDROCHLORIDE | 1 | 1 DF, 1X/DAY (EVERY 24 HOURS) | 0 | 1 | DF | QD | ||||||||
| 113742663 | 11374266 | 8 | C | PROFER /00023527/ | 2 | 1 DF, 2X/DAY | 0 | 1 | DF | BID | |||||||||
| 113742663 | 11374266 | 9 | C | INSULIN | INSULIN NOS | 1 | 4 DF, 1X/DAY (BREAKFAST, LUNCH AND DINNER AND OTHER BEFORE GO TO BED) | 0 | 4 | DF | QD | ||||||||
| 113742663 | 11374266 | 10 | C | ABIXA | 2 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||||
| 113742663 | 11374266 | 11 | C | EXFORGE HCT | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEVALSARTAN | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
| 113742663 | 11374266 | 12 | C | ZOMARIST /06202201/ | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | 3 DF, 1X/DAY | 0 | 3 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113742663 | 11374266 | 1 | Rheumatoid arthritis |
| 113742663 | 11374266 | 4 | Pain |
| 113742663 | 11374266 | 5 | Prophylaxis |
| 113742663 | 11374266 | 6 | Pain |
| 113742663 | 11374266 | 8 | Thalassaemia |
| 113742663 | 11374266 | 9 | Diabetes mellitus |
| 113742663 | 11374266 | 10 | Blood cholesterol |
| 113742663 | 11374266 | 11 | Hypertension |
| 113742663 | 11374266 | 12 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113742663 | 11374266 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113742663 | 11374266 | Abasia | |
| 113742663 | 11374266 | Condition aggravated | |
| 113742663 | 11374266 | Drug ineffective | |
| 113742663 | 11374266 | Fatigue | |
| 113742663 | 11374266 | Pyrexia | |
| 113742663 | 11374266 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113742663 | 11374266 | 1 | 20150411 | 0 |